Use of Gadoxetic Acid–enhanced Liver MRI and Mortality in More than 30 000 Patients with Hepatocellular Carcinoma: A Nationwide Analysis

Background The impact on survival of gadoxetic acid–enhanced MRI in addition to multiphase contrast material–enhanced CT for initial staging in patients with hepatocellular carcinoma (HCC) is unknown. Purpose To compare all-cause mortality in patients with HCC who underwent CT only, CT plus non–gadoxetic acid–enhanced MRI, or CT plus gadoxetic acid–enhanced MRI as part of their initial diagnostic work-up. Materials and Methods The authors...